Acotec Scientific (HKG:6669) obtained registration approval for the peripheral controlled mechanically detachable fibered coil from China's National Medical Products Administration, a Monday Hong Kong bourse filing said.
Shares of the interventional medical device manufacturer were down over 6% in Tuesday afternoon trading.
The product is indicated for the embolization of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.